16 Recruiting Studies Using Adagrasib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Adagrasib
Genetic Testing in Guiding Treatment for Patients With Brain Metastases
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
CDK Gene Mutation
View Study & Checklist ➔Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
📍 Local Institution - 101 — Santa Rosa, California
Advanced Cancer
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer
📍 Banner Health MD Anderson AZ — Gilbert, Arizona
Non-Small Cell Lung Cancer
View Study & Checklist ➔Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation
📍 Local Institution - 017-936C — Fountain Valley, California
Advanced NSCLC
View Study & Checklist ➔CIMAvax-EGF With KRAS G12C Inhibitor for the Treatment of Advanced, KRAS G12C Mutated Non Small Cell Lung Cancer
📍 Roswell Park Cancer Institute — Buffalo, New York
Advanced Lung Non-Small Cell Carcinoma
View Study & Checklist ➔ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
📍 MD Anderson Cancer Center — Houston, Texas
Dynamic Tumor Resistance
View Study & Checklist ➔A Study to Assess the Pharmacokinetics, Safety and Tolerability of Single-dose Adagrasib (BMS-986503) in Healthy Participants of Japanese Descent
📍 CenExel ACT (Formerly Anaheim Clinical Trials; LLC) — Anaheim, California
Healthy Participants
View Study & Checklist ➔KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
📍 Mayo Clinic Comprehensive Cancer Center — Phoenix, Arizona
Solid Tumors With HRAS Alterations
View Study & Checklist ➔A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
Metastatic Colorectal Cancer
View Study & Checklist ➔Phase 1 Study Of Izalontamab Brengitecan + Adagrasib In NSCLC - The IZA-A Trial
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
Non-small Cell Lung Cancer
View Study & Checklist ➔A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
📍 John Theurer Cancer Center at Hackensack University Medical Center — Hackensack, New Jersey
Advanced Malignant Tumors
View Study & Checklist ➔Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
📍 CTCA at Western Regional Medical Center — Goodyear, Arizona
Lung Non-Small Cell Carcinoma
View Study & Checklist ➔Adagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain Metastases
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
Non Small Cell Lung Cancer
View Study & Checklist ➔A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
📍 Local Institution - 0005 — Phoenix, Arizona
Solid Tumors
View Study & Checklist ➔A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
📍 Local Institution - 0347 — Birmingham, Alabama
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
📍 Local Institution - 007-556-A — Goodyear, Arizona
Advanced Non-Small Cell Lung Cancer
View Study & Checklist ➔